ArticleProceedings of the National Academy of Sciences of the United States of America2018

Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.

Andrew V Schally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.